Drug design : cutting edge approaches
Pharmaceutical research draws on increasingly complex techniques to solve the challenges of drug design. Bringing together a number of the latest informatics techniques, this book looks at modelling and bioinformatic strategies; structural genomics and X-ray crystallography; virtual screening; lead...
Saved in:
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cambridge, UK :
Royal Society of Chemistry,
©2002.
|
| Series: | Special publication (Royal Society of Chemistry (Great Britain)) ;
no. 279. |
| Subjects: | |
| ISBN: | 0854048162 9780854048168 9781847550705 1847550703 1601190271 9781601190277 |
| Physical Description: | 1 online resource (x, 192 pages) : illustrations |
Cover
Table of contents
| LEADER | 05718cam a2200649 a 4500 | ||
|---|---|---|---|
| 001 | kn-ocm71842195 | ||
| 003 | OCoLC | ||
| 005 | 20240717213016.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 061005s2002 enka ob 101 0 eng d | ||
| 040 | |a KNOVL |b eng |e pn |c KNOVL |d TEF |d BAKER |d OCLCQ |d CUS |d OCLCQ |d AU@ |d OKU |d ZOZ |d UKRSC |d U5D |d N$T |d OCLCO |d E7B |d KNOVL |d ZCU |d KNOVL |d COO |d OCLCE |d OCLCQ |d NLGGC |d OCLCO |d KNOVL |d OCLCQ |d OCLCO |d MHW |d EBLCP |d DHA |d OCLCQ |d OCLCF |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d YDXCP |d AZK |d LOA |d OCLCO |d OCLCA |d COCUF |d UAB |d MOR |d CCO |d OCLCO |d PIFAG |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d IGB |d OCLCO |d OCLCA |d U3W |d NJR |d BUF |d MERER |d CUY |d D6H |d CN8ML |d OCL |d OCLCQ |d INARC |d STF |d VNS |d WRM |d OCLCO |d VTS |d RRP |d OCLCQ |d ICG |d NLE |d NRAMU |d VT2 |d OCLCQ |d UKMGB |d WYU |d OCLCO |d OCLCQ |d S9I |d OCLCO |d OCLCA |d LEAUB |d OCLCQ |d DKC |d OCLCQ |d M8D |d OCLCO |d LIP |d UKAHL |d U3G |d CEF |d UX1 |d OL$ |d OCLCO |d OCLCQ |d AUD |d IEUOL |d HS0 |d UWK |d ERF |d ADU |d UKBTH |d NLW |d OCLCQ |d OCLCA |d OCLCQ |d ZHM |d OCLCA |d UKCRE |d MM9 |d OCLCQ |d OCLCO |d OCLCQ |d DGN |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCQ |d OCLCL | ||
| 020 | |a 0854048162 |q (electronic bk.) | ||
| 020 | |a 9780854048168 |q (electronic bk.) | ||
| 020 | |a 9781847550705 |q (electronic bk.) | ||
| 020 | |a 1847550703 |q (electronic bk.) | ||
| 020 | |a 1601190271 | ||
| 020 | |a 9781601190277 | ||
| 035 | |a (OCoLC)71842195 |z (OCoLC)223451489 |z (OCoLC)227344036 |z (OCoLC)232637347 |z (OCoLC)643999007 |z (OCoLC)692544141 |z (OCoLC)843641090 |z (OCoLC)956412965 |z (OCoLC)961676667 |z (OCoLC)962603551 |z (OCoLC)965973944 |z (OCoLC)974761253 |z (OCoLC)974861637 |z (OCoLC)988510382 |z (OCoLC)991927432 |z (OCoLC)1011791137 |z (OCoLC)1018008840 |z (OCoLC)1027301074 |z (OCoLC)1033597340 |z (OCoLC)1037795165 |z (OCoLC)1038621107 |z (OCoLC)1043609968 |z (OCoLC)1045533012 |z (OCoLC)1058680462 |z (OCoLC)1062277799 |z (OCoLC)1065672995 |z (OCoLC)1086496665 |z (OCoLC)1086548919 |z (OCoLC)1086959117 |z (OCoLC)1100830016 |z (OCoLC)1101728632 |z (OCoLC)1102536871 |z (OCoLC)1105590595 |z (OCoLC)1107151044 |z (OCoLC)1109315105 |z (OCoLC)1110319404 |z (OCoLC)1110807487 |z (OCoLC)1113253634 |z (OCoLC)1113602781 |z (OCoLC)1119034541 |z (OCoLC)1119428704 |z (OCoLC)1119976237 |z (OCoLC)1120919989 |z (OCoLC)1153542051 |z (OCoLC)1157039021 |z (OCoLC)1159638435 |z (OCoLC)1228528273 |z (OCoLC)1409106773 | ||
| 042 | |a dlr | ||
| 245 | 0 | 0 | |a Drug design : |b cutting edge approaches / |c edited by Darren R. Flower. |
| 260 | |a Cambridge, UK : |b Royal Society of Chemistry, |c ©2002. | ||
| 300 | |a 1 online resource (x, 192 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Special publication ; |v no. 279 | |
| 500 | |a "The proceedings of the meeting on Cutting Edge Approaches to Drug Design held on 13 March 2001 at the Scientific Societies Lecture Theatre, London, UK"--Title page verso | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Molecular informatics : sharpening drug design's cutting edge -- High-throughput X-ray crystallography for drug discovery -- Trawling the genome for G protein-coupled receptors : the importance of integrating bioinformatic approaches -- Virtual screening of virtual libraries : an efficient startegy for lead generation -- Virtual techniques for lead optimisation -- The impact of physical organic chemistry on the control of drug-like properties -- Mutagenesis and modelling highlight the critical nature of the TM2-loop-TM3 region of biogenic amine GPCRs -- Computational vaccine design. | |
| 506 | |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty | ||
| 520 | |a Pharmaceutical research draws on increasingly complex techniques to solve the challenges of drug design. Bringing together a number of the latest informatics techniques, this book looks at modelling and bioinformatic strategies; structural genomics and X-ray crystallography; virtual screening; lead optimisation; ADME profiling and vaccine design. A number of relevant case studies, focussing on techniques that have demonstrated their use, will concentrate on G-protein coupled receptors as potential disease targets. Providing details of state-of-the-art research, Drug Design: Cutting Edge Approaches will be invaluable to all drug discovery scientists, including medicinal and combinatorial chemists, molecular modellers, bio- and chemoinformaticians, and pharmacologists, amongst others. | ||
| 590 | |a Knovel |b Knovel (All titles) | ||
| 650 | 0 | |a Drugs |x Design |v Congresses. | |
| 650 | 0 | |a Drugs |x Design |x Mathematical models |v Congresses. | |
| 650 | 0 | |a Artificial intelligence |x Medical applications |v Congresses. | |
| 650 | 0 | |a Drugs |x Research |x Methodology |v Congresses. | |
| 650 | 0 | |a Mathematical models. | |
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Chemistry. | |
| 650 | 0 | |a Physical sciences. | |
| 650 | 0 | |a Life sciences. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 0 | |a Methodology. | |
| 650 | 0 | |a Chemical models. | |
| 650 | 0 | |a Molecular pharmacology |x Computer simulation. | |
| 650 | 0 | |a Pharmacology, Experimental |x Computer simulation. | |
| 650 | 0 | |a Computer simulation. | |
| 650 | 0 | |a Digital computer simulation. | |
| 655 | 7 | |a elektronické knihy |7 fd186907 |2 czenas | |
| 655 | 9 | |a electronic books |2 eczenas | |
| 700 | 1 | |a Flower, Darren R. | |
| 776 | 0 | 8 | |i Print version: |t Drug design. |d Cambridge, UK : Royal Society of Chemistry, ©2002 |z 0854048162 |w (DLC) 2006270060 |w (OCoLC)48979833 |
| 830 | 0 | |a Special publication (Royal Society of Chemistry (Great Britain)) ; |v no. 279. | |
| 856 | 4 | 0 | |u https://proxy.k.utb.cz/login?url=https://app.knovel.com/hotlink/toc/id:kpDDCEA008/drug-design-cutting?kpromoter=marc |y Full text |
Save to List
Cite this
Export Record
Email this